Biotechnology

Broncus Completed the First-in-man Clinical Trial of Its Targeted Lung Denervation Radiofrequency Ablation System

HONG KONG, Sept. 30, 2021 /PRNewswire/ -- Broncus Holding Corporation ("Broncus" or the "Company") is pleased to announce that it has completed the first-in-man clinical trial of its Targeted Lung Denervation (TLD) radiofrequency ablation system, which is expected to benefit patients with chroni...

2021-09-30 19:40 3570

Zantrene® kills melanoma cancer cells that overproduce FTO

* Zantrene® at low concentrations kills high FTO producing melanoma cancer cells * Sensitivity to Zantrene® correlates with FTO levels, where high FTO producing cells show up to 60x greater sensitivity than low FTO producing cells * Results are highly supportive of future clinical trials in ...

2021-09-30 11:58 11117

GenFleet and Innovent Starts First-in-human Phase I/II Trial of KRAS G12C Inhibitor

GUANGZHOU, China, Sept. 29, 2021 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, and Innovent Biologics (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercialize...

2021-09-30 08:05 2314

Recbio and Rhegen Signed an mRNA Vaccine Cooperation Agreement

TAIZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (referred to as "Recbio") and Shenzhen Rhegen Biotechnology Co., Ltd. (referred to as "Rhegen Bio") recently signed a joint venture agreement to establish a joint venture company "Wuhan Rhecogen Biotechnology Co., ...

2021-09-29 19:37 3917

Hong Kong's first biotech firm to cultivate microalgae for its abundant plant-based protein for consumer application

HONG KONG, Sept. 29, 2021 /PRNewswire/ -- The bioscience start-up, Geb Impact Technology Company Limited has developed an advanced technology to rapidly cultivate clear water single-celled microalgae. Microalgae are the abundant and sustainable source of high-quality plant-based protein, fit for ...

2021-09-29 18:26 3421

Reversing Asia Pacific's biodiversity and nature loss crisis could result in US$4.3 trillion worth of nature-positive business opportunities

* A new study by AlphaBeta, Temasek and the World Economic Forum estimates that 63 percent ofAsia Pacific's GDP, US$19.5 trillion, is threatened by biodiversity and nature loss * It also identifies 59 nature-positive business opportunities that can unlock US$4.3 trillion in business value and ...

2021-09-29 15:36 4729

Molecular Stethoscope, Inc. Announces Presentation at 16th Annual Sequencing to Function: Analysis and Applications for the Future Meeting

Presentation highlights a path forward to lead the development of the Company's clinical-grade Next-Generation cf-mRNA Liquid Biopsy-Artificial Intelligence Technology Platform PALO ALTO, Calif., Sept. 29, 2021 /PRNewswire/ -- Molecular Stethoscope, Inc., a Precision Medicine biotechnology compa...

2021-09-29 15:00 2552

Innovent Releases Preliminary Results of the Phase Ia Dose-Escalation study of IBI315 (Anti-Her2/PD-1 Bispecific Antibody) in Patients with Advanced Solid Tumors at CSCO Annual Meeting 2021

SAN FRANCISCO and SUZHOU, China, Sept. 29, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major dise...

2021-09-29 08:00 4199

Lifebit raises $60m to make vital biomedical data securely accessible for life changing research worldwide

LONDON, Sept. 29, 2021 /PRNewswire/ -- Lifebit Biotech Ltd – the leading precision medicine software company democratising access to biomedical data for governments, healthcare providers and research teams worldwide – has raised a $60 million Series B funding round, led by global investment firm T...

2021-09-29 08:00 5942

MetaCell launches innovative Cloud Hosting for life science and healthcare

CAMBRIDGE, Mass., Sept. 29, 2021 /PRNewswire/ -- MetaCell, an innovative life science software company specialized in creating cutting-edge research software for major pharma, biotech, and academic institutions, has launchedMetaCell Cloud Hosting

2021-09-29 07:54 2651

BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission

VANCOUVER, BC, Sept. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF)("BioVaxys" or "Company"), announced today that it has started its plannedin vivo animal toxicology study of CoviDTH in parallel with the preparation of an IND submission. Under the terms ...

2021-09-28 20:00 7424

Zymo Research Pays it Forward With Their Commitment to Eradicate the COVID-19 Pandemic in India

DNA/RNA Shield – DirectDetect™ reagent eliminates RNA extraction for rapid deployment of COVID-19 tests in affected countries IRVINE, Calif., Sept. 28, 2021 /PRNewswire/ -- Zymo Research has donated one million COVID-19 test kits that include its newDNA/RNA Shield - DirectDetect™ reagent and col...

2021-09-28 14:57 3286

Insectmeal outcompetes fishmeal in shrimp diets

SINGAPORE, Sept. 28, 2021 /PRNewswire/ -- Singapore headquartered, Nutrition Technologies, recently announced the results of their recent trial using the alternative protein, Black Soldier Fly Meal ("BSF meal"), to replace fishmeal in shrimp diets. The trial found that shrimp fed with diets using...

2021-09-28 12:27 3547

Innovent and UNION Therapeutics Enter into Strategic Collaboration and License Agreement for Orismilast, a Next-generation PDE4 Inhibitor for Inflammatory Dermatology Conditions

SAN FRANCISCO and SUZHOU, China and HELLERUP, Denmark, Sept. 28, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmun...

2021-09-28 08:00 4407

Neurophth Announces the Completion of GMP Manufacturing Facility for Gene Therapy Products According to International Standards

WUHAN, China and SAN DIEGO, Sept. 27, 2021 /PRNewswire/ -- Neurophth Biotechnology Ltd., a fully-integrated genomic medicines company seeking to improve lives through the curative potential of gene therapies, announced the opening of its state-of-the-art manufacturing facility at the Phase II Suz...

2021-09-27 23:00 2395

Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase III Trial in Patients with Generalized Myasthenia Gravis

CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 27, 2021 /PRNewswire/ -- Harbour BioMed ("HBM", HKEX: 02142) announced that, the clinical trial of its anti-FcRn antibody, batoclimab (HBM9161), has completed the first dosing of first patient in registrational phase III trial f...

2021-09-27 21:03 5255

Foresees the Future Trend of Laboratory Technology

BEIJING, Sept. 27, 2021 /PRNewswire/ -- On September 27, 2021, NIKYANG made a stunning appearance at the 19th Beijing Conference and Exhibition on Instrumental Analysis (BCEIA 2021) with its latest innovative laboratory automation solutions that are essentially used for the drug R&D analysis and ...

2021-09-27 21:03 1957

JW Therapeutics Announces IND Approval for the Clinical Trial of JWCAR129

SHANGHAI, Sept. 27, 2021 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, today announced that it has received the Investigational New Drug (IND) clearance from the National Medi...

2021-09-27 20:00 4594

Senhwa Announces Acceptance of Early Positive COVID-19 Phase II Study Abstract for Presentation at the ISIRV-WHO Conference

* Early Positive Phase 2 efficacy and safety data are both statistically significant and clinically meaningful. * No SAE related to Silmitasertib was reported. * Silmitasertib is a host-directed antiviral and an anti-inflammatory investigational therapy expected to be effective against eme...

2021-09-27 19:20 3326

Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC

* Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in theAtlanta, GA, United States * AIOS is the MDx system that integrates Seegene's liquid handler and real-time PCR instruments. * Seegene MDx system will efficiently access a wide ...

2021-09-27 19:02 3244
1 ... 322323324325326327328 ... 349